SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-025891
Filing Date
2022-10-03
Accepted
2022-10-03 17:18:40
Documents
15
Period of Report
2022-10-03
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20221003.htm   iXBRL 8-K 49520
2 EX-3.1 exhibit31-biohavenpharmace.htm EX-3.1 198835
6 bvilogoa.jpg GRAPHIC 134364
7 walkerslogoa.jpg GRAPHIC 66922
  Complete submission text file 0001628280-22-025891.txt   703860

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20221003.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20221003_lab.xml EX-101.LAB 24801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20221003_pre.xml EX-101.PRE 13237
9 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20221003_htm.xml XML 11036
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 221288601
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences